August Rush, o filme de 2007 indicado ao Oscar e ao Grammy, está sendo desenvolvido como um novo musical da Broadway. Um workshop de August Rush: A New Musical, dirigido pela vencedora de três Tony ...
No início desta semana, Titanique e Beaches: The Musical anunciaram em rápida sucessão que irão ocupar, respectivamente, os teatros St. James e Majestic, cada um por um período limitado nesta ...
Novo Nordisk has won the race to secure approval from the U.S. Food and Drug Administration for the first weight-loss drug to be administered orally. Jules Rimmer is a markets reporter in ...
A cantora inglesa lançou o disco 'West End Girl' em outubro deste ano Globo confirma morte de Luciene Silva aos 58 anos Não compro mais picolé desde que descobri isso! #picolé #economia Câmeras ...
Filipe La Feria recebeu este fim de semana a medalha de mérito cultural. O momento aconteceu antes da estreia de um novo musical, desta vez, sobre Carmen Miranda. Informações preocupantes sobre Putin ...
O Ministério da Cultura autorizou a Casamata Produções Artísticas a captar, via Lei Rouanet, até 3,9 milhões de reais para montar o musical Timbalada – Ritmo, Cor e História. A produção itinerante ...
FDA approves Novo Nordisk's weight-loss pill Novo aims to regain market share from Eli Lilly Pill broadens potential patient pool The pill is 25 milligrams of semaglutide, the same active ingredient ...
Dec 18 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Thursday it had filed a marketing application with the U.S. Food and Drug Administration for CagriSema, its once-weekly ...
Novo Nordisk NOVO.B1.08%increase; green up pointing triangle filed for U.S. Food and Drug Administration approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity.
Novo Nordisk wins FDA approval for Wegovy in a pill, introducing first oral GLP-1 option for obesity
After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.
When Novo Nordisk launched Wegovy, its pioneering weight-loss jab, in America in June 2021, it felt like it was “running into a dark tunnel”, recalls Maziar Mike Doustdar, who took over as the Danish ...
Every chief executive dreams of it: a product so successful that it propels their company from obscurity to superstardom seemingly overnight. Among the lessons from 2025, however, is that runaway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback